COVID-19 Scan for May 26, 2020

News brief

Study: Low oxygen, inflammation predict critical COVID-19 illness, death

Low oxygen levels at hospital admission and signs of inflammation were the strongest predictors of serious COVID-19 illness and death in a prospective cohort study published late last week in BMJ.

Researchers found that 2,741 (51.9%) of 5,279 people testing positive for COVID-19 from Mar 1 to Apr 8 were hospitalized in NYU Langone Health in New York City and Long Island. Of the 2,741 hospitalized patients, 1,739 (69.5%) were released from the hospital, 990 (36.1%) were critically ill, and 665 (24.3%) were released to hospice or died.

Of the 990 critically ill patients, 647 (65.4%) needed mechanical ventilation, 102 (10.3%) needed intensive care but not mechanical ventilation, and 241 (24.3%) were released to hospice or died without receiving either intensive care or mechanical ventilation. Of the 647 patients (23.6%) needing mechanical ventilation, 391 (60.4%) died, and 170 (26.2%) were extubated or released from the hospital.

Advanced age was the strongest predictor of hospitalization, with a double or higher risk for all age-groups older than 44 years and 37.9 odds ratio (95% confidence interval, 26.1 to 56.0) for those 75 years and older.

Risk factors for hospitalization and critical illness also included heart failure, male sex, chronic kidney disease, and body mass index (BMI) greater than 40. But oxygen saturation at hospital admission of less than 88% and high levels of the inflammatory markers troponin, C-reactive protein, and D-dimer were more strongly linked to serious illness than age or underlying illnesses.

Median length of hospitalization was 7 days for all hospitalized coronavirus patients and 36 days for those with serious illness. Of all hospitalized coronavirus patients, 94% have been released from the hospital to hospice or have died.

The risk of serious illness and death declined during the study period, with the lowest risk in the last week, which "raises the possibility that familiarity with the disease, ongoing iteration of protocols and practices in response to observed outcomes, and initiation of new treatments might improve outcomes even in the absence of vaccination or regimens known to be effective," the authors wrote.
May 22 BMJ study

COVID-19 cuts large swath of critical illness, death on West Coast, study finds

The likelihood of COVID-19 patients needing intensive care in Kaiser Permanente healthcare systems in California and Washington state was 40.7%, and the risk of death was 18.9%, according to a prospective cohort study also published in BMJ.

As of Apr 22, 1,840 health system members were hospitalized with COVID-19, including 678 in northern California, 1,059 in southern California, and 103 in Washington. The case-fatality rate was 23.5% in men and 14.9% in women. Risk of death increased with age for both sexes, peaking at 37.3% in hospitalized patients 80 years or older.

Men were more likely than women to require intensive care (48.5% vs 32.0%) and to die (23.5% vs 14.9%). Of the 1,328 people hospitalized by Apr 9 who had 14 days or more of follow-up at data analysis, median patient age was 61 years (range, 18 to 103), with 50% of them 48 to 72 years old, 4 (0.3%) younger than 20 years, 528 (39.8%) 65 years or older, and 162 (12.2%) 80 years or older; 741 (55.8%) were men. Probability of intensive care unit (ICU) admission was 48.5% for men and 32.0% for women.

People infected with COVID-19 on Mar 1 were estimated to infect, on average, 1.39 to 1.54 other people. After public health measures were implemented, the number declined to less than 1, meaning transmission of the virus was slowing.

Median length of hospitalization was 9.3 days among survivors and 12.7 days among those who died. Median length of ICU stay was 10.6 days.

The long median hospital stay indicates that unmitigated transmission of the novel coronavirus could overwhelm US hospital capacity, as it did in Italy and New York City, the authors said. "Hospitals should ensure capacity to manage patients with COVID-19 in the coming months in a manner that is responsive to changes in social distancing or other pandemic mitigating measures," they wrote.
May 22 BMJ study

 

Swiss study indicates children infrequently transmit COVID-19 to adults

A study today in Pediatrics looked at COVID-19 transmission dynamics in 39 Swiss family household clusters of illnesses and identified only 3 (8%) in which a child was the suspected index patient. The study suggests children most commonly contract the virus from adults, and not vice versa and could favor school reopening.

The study was conducted Mar 10 through Apr 10 via Geneva University Hospital's surveillance network, with 40 children under the age of 16 diagnosed as having COVID-19. Household contact (HHC) information was collected for 39 of those cases. Only 3 households reported having a child with symptom onset preceding any illness in adults. No patients identified in the study required intensive care unit admission, and all saw symptoms resolve within 7 days of infection.

"85% (75/88) of adult HHC developed symptoms at some point, compared to 43% (10/23) of pediatric HHC (p<0.001). Also, 92% (36/39) of mothers developed symptoms, compared to 75% (24/32) of fathers (p=0.04)," the authors wrote.

In a commentary on the study, Benjamin Lee, MD and William V. Raszka, Jr, MD both of the University of Vermont Larner College of Medicine, write that the findings add to a small but growing body of literary that offer encouragement for school reopening. They note that data so far "provide early reassurance that school-based transmission could be a manageable problem and school closures may not have to be a foregone conclusion, particularly for elementary school aged-children who appear to be at the lowest risk of infection."
May 26 Pediatrics study
May 26 Pediatrics
commentary

French study finds high antibiotic use for viral respiratory infections in kids

An assessment of community antibiotic prescribing in French children found high rates of prescribing for viral respiratory tract infections (RTIs) and broad-spectrum antibiotic use, particularly among clinicians 50 years and older, French researchers reported yesterday in the Journal of Antimicrobial Chemotherapy.

The analysis looked at 221,768 pediatric visits in a national sample of 680 French general practitioners (GPs) and 70 community pediatricians from March 2015 to February 2017. The researchers calculated antibiotic prescription rates per 100 visits separately for GP and pediatricians, and assessed broad-spectrum antibiotic use and duration of treatment for RTIs. The results showed that, overall, GPs prescribed more antibiotics than pediatricians, with a prescription rate of 26.1 per 100 visits (95% confidence interval [CI], 25.9 to 26.3) versus 21.6 for pediatricians (95% CI, 21 to 22).

RTIs accounted for more than 80% of antibiotic prescriptions, with presumed viral RTIs being responsible for 40.8% and 23.6% of all antibiotic prescriptions by GPs and pediatricians, respectively. For RTIs, GPs prescribed more broad-spectrum antibiotics than pediatricians (49.8% vs 35.6%), while antibiotic course duration was similar. After adjustment for diagnosis, antibiotic prescribing rates were not associated with season and patient age, but were significantly higher among GPs over 50.

"We suggest that future antibiotic stewardship campaigns should emphasize: zero antibiotic prescribing for presumed viral RTIs (notably bronchitis, common cold and cough), further reducing broad-spectrum antibiotic prescribing and more effective communication towards GPs, especially those older than 50 years of age," the authors wrote.
May 25 J Antimicrob Chemother abstract

 

Higher antibiotic prescribing found in more deprived areas of Wales

In another study yesterday in the Journal of Antimicrobial Chemotherapy, researchers in Wales reported that antibiotic prescribing is higher among GP practices in poorer parts of the country.

Analyzing data on nearly 3 million patients from 339 GP practices, researchers from Cardiff University found that approximately 9 million oral antibiotics were prescribed from 2013 through 2017. Antibiotic prescribing rates per person varied by levels of socioeconomic status (SES), with the rate in the most deprived areas of the country being 26% higher than in the least deprived. The association between deprivation and antibiotic prescribing persisted after controlling for demographic variables, smoking, chronic conditions, and clustering by GP practice and GP cluster. Those living in areas in the most deprived quintile in Wales received 18% more antibiotic prescriptions (incidence rate ratio [IRR], 1.18; 95% CI, 1.18 to 1.19) than those with similar demographics, chronic conditions and smoking status but living in areas in the least deprived quintile.

The authors of the study say the higher prescribing rates seen in more deprived areas could be because people in lower SES groups consult healthcare providers more frequently and may consult more frequently for infections. In addition, prescribers could be more concerned about increased risk of complications in this group. They say the findings may be generalizable to other countries with similar settings and healthcare delivery systems.
May 25 J Antimicrob Chemother abstract

 

Retrospective probable case added to DRC Ebola total

Though no new confirmed cases have been reported in the Democratic Republic of the Congo (DRC) over the past 29 days, on May 22 health officials added one probable retrospective case, according to the latest weekly outbreaks and emergencies report from the World Health Organization (WHO) African regional office.

The probable retrospective case involves a patient from Mabalako, raising the overall case count to 3,463 and the number of probable cases to 146. The fatality count is 2,280.

The DRC is in the midst of a 42-day countdown until the outbreak is considered over, following a cluster of seven cases, four of them fatal, reported in the middle of April. One of the patients was lost to follow-up on May 16 after leaving a temporary isolation facility.

The WHO said efforts are still under way to find the patient and to investigate the source of the recent cluster. It said the long duration and large size of the outbreak—which began in August 2018—underscore the re-emergence risk and added that it's important to maintain strong surveillance to detect, isolate, test, and treat new suspected case-patients.
May 25 WHO African regional office weekly report

 

H9N2 avian flu infects 2 children in China

China has detected two more H9N2 avian flu infections, both involving children, according to a statement from Taiwan Centers for Disease Control, translated and posted by Avian Flu Diary (AFD).

One of the patients is a 6-year-old boy from the city of Weihai in Shandong province in eastern China, and the other is a 10-month-old boy from Xiamen in Fujian province, which is located in the southeast. Both boys had a history of contact with live poultry or poultry markets before they got sick. Their symptoms were mild, and they have since recovered.

Taiwan officials said seven H9N2 cases have been reported from the mainland since October 2019. The World Health Organization has said H9N2 is enzootic in Asian poultry. Human infections are rare, but when they do occur, children are more likely to be affected, and illnesses are typically mild.
May 25 AFD post

 

Ethiopia detects seven suspected Guinea worm infections

Ethiopia reported to the WHO seven suspected cases of human Guinea worm infections (dracunculiasis) detected in early April in the Gog district of the Gambella region.

The infections come more than 2 years after the last human Guinea worm cases were detected in that country.

"All the infected people used unsafe drinking water from farm ponds. These water sources were reported to be associated with the baboon infection in June 2019 in the same village," the WHO said. Worm specimens have been sent to the US Centers for Disease Control and Prevention for confirmation.
May 25 WHO update

This week's top reads